ロード中...
Tonabersat Inhibits Connexin43 Hemichannel Opening and Inflammasome Activation in an In Vitro Retinal Epithelial Cell Model of Diabetic Retinopathy
This study was undertaken to evaluate the connexin hemichannel blocker tonabersat for the inhibition of inflammasome activation and use as a potential treatment for diabetic retinopathy. Human retinal pigment epithelial cells (ARPE-19) were stimulated with hyperglycemia and the inflammatory cytokine...
保存先:
| 出版年: | Int J Mol Sci |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7794685/ https://ncbi.nlm.nih.gov/pubmed/33396676 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22010298 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|